MiMedx Group (MDXG) Earnings Date & Reports

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MDXG is expected to report earnings to fall 17.86% to 5 cents per share on April 30

MiMedx Group MDXG Stock Earnings Reports

Q1'25

Est.

$0.06

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.03

Q2'24

Est.

$0.08

Q1'24

Beat

by $0.02

The last earnings report on February 26 showed earnings per share of 7 cents, beating the estimate of 5 cents. With 406.85K shares outstanding, the current market capitalization sits at 1.00B.

View a ticker or compare two or three

Compare

MDXG